Invo Fertility reports $2.02 million Q1 revenue

• INVO Fertility reported a 23% year-over-year increase in Q1 2026 total revenue to $2.02 million.
• Total liabilities fell by 26% to $9.6 million, while stockholders' equity rose 108% to $15 million following balance sheet restructurings.
• Corporate growth was driven by the acquisition of the Family Beginnings clinic, expanding the domestic operational footprint.

INVO Fertility (NASDAQ:IVF) recorded a 23% increase in year-over-year revenue to $2.02 million for the first quarter of 2026.

This growth reflects an expansion compared to the same period last year, with consolidated clinic revenue rising 22% to $1.98 million.

The company reported a net loss from continuing operations of $5.5 million, which included a $3.8 million non-cash warrant loss.

Total liabilities fell 26% to $9.6 million, while stockholders' equity rose 108% to $15 million following the elimination of all Series C-2 Preferred Stock and warrant liabilities.

Operational activity during the quarter featured the completion of the Family Beginnings clinic acquisition.

The company stated that this transaction successfully brings its total U.S. clinic footprint to four locations.